Tenderwize
Back to tender search

Delivery of general hospital medicinal products for UMBAL Dr. Georgi Stranski EAD - Pleven

УНИВЕРСИТЕТСКА МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - Д-Р ГЕОРГИ СТРАНСКИ ЕАД·гр. Плевен, Bulgaria·BGN 44.2M·Deadline Feb 07, 2028 · 530 days left·Restricted·Supplies·DPS
Sign up to saveOpen documents
Structured notice only
Original notice title

Bulgaria – Pharmaceutical products – Доставка на общоболнични лекарствени продукти за нуждите на „УМБАЛ Д-р Георги Странски” ЕАД – гр. Плевен

70/100

Opportunity Score

Needs reviewMedium complexity
SuppliesDPSOpen
Why this score?

Opportunity

70 / 100

Complexity

65 / 100

Risk factors

Notice type is 'cn-standard' (contract award) subtype 16, but the procedure is flagged as a DPS with restricted procedu...

Structured data indicates EU-funded (isEuFunded: true), but XML notice shows 'FundingProgramCode: no-eu-funds'. This af...

Restricted procedure — pre-qualification required

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • BGN 44.2M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 36 MONTH
  • Supply of 655 hospital pharmaceutical products (general medicines) to UMBAL Dr. Georgi Stranski EAD in Pleven, Bulgaria
  • Deliveries made upon written requests over a 36-month period
Show full summary

This tender by University Multi-Profile Hospital for Active Treatment 'Dr. Georgi Stranski' EAD - Pleven (Bulgaria) seeks a supplier for the delivery of 655 general hospital pharmaceutical products via a Dynamic Purchasing System (DPS) under a restricted procedure. The estimated total value is BGN 44,239,186.49 (approx. €22.6M) for a 36-month period. Award is based solely on lowest price. The notice is a contract award (cn-standard) with subtype 16, but the DPS nature and long deadline (2028) raise procedural ambiguities. The structured data indicates EU funding, but the XML notice states no EU funds. Only notice-level data was analyzed; procurement documents were not reviewed.

Risks

Notice type is 'cn-standard' (contract award) subtype 16, but the procedure is flagged as a DPS with restricted procedu...

Structured data indicates EU-funded (isEuFunded: true), but XML notice shows 'FundingProgramCode: no-eu-funds'. This af...

Restricted procedure — pre-qualification required

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Tenderer must be registered as a trader with the right to wholesale medicinal products
  • Must hold a wholesale distribution authorization from the Bulgarian Drug Agency (IAL) or equivalent EU authority
  • If producer, must hold a manufacturing authorization; otherwise, an authorization from the manufacturer

Requirements may be incomplete.

Award Criteria

Lot 1

Award based solely on lowest total price for the lot; no other criteria.

Buyer

Location

гр. Плевен, BGR

Buyer profile

Open profile

Identifier

114532352

Activity

Health

Lots (1)

LOT-0001

Delivery of general hospital medicinal products for UMBAL Dr. Georgi Stranski EAD - Pleven

Single lot covering the supply of 655 different hospital pharmaceutical products, delivered as needed per written requests over 36 months. The lot is part of a DPS with restricted procedure. Performance location: Pleven, Bulgaria (BG314).

SuppliesDPSEU fundedElectronic submission

BGN 44.2M

Estimated value

Location

Плевен, Bulgaria

Duration

36 MONTH

Category

Pharmaceutical products

Award Criteria

Price

Deadline

Deadline Feb 07, 2028

Procurement Details

Publication date
17 Feb 2025
Languages
Bulgarian

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
107390-2025

Documents (1)

Procurement document 1

Similar tenders

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3